| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | C/O OPUS GENETICS, INC., 8 DAVIS DRIVE, SUITE 220, DURHAM | /s/ Amy Rabourn, by Power of Attorney | 17 Feb 2026 | 0002008983 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IRD | Common Stock | Tax liability | $18,011 | -5,313 | -1% | $3.39 | 520,494 | 12 Feb 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The Issuer withheld the shares reported on this line to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. Not an open market sale of securities. |